A Second Team Pursues Cimavax Commercialization in the U.S.

A Second Team Pursues Cimavax Commercialization in the U.S.

Cuba’s Cimavax gained media attention last month when Roswell Park Cancer Institute in Buffalo, New York announced that the U.S. Food and Drug Administration (FDA) had approved clinical trials there as part of a collaboration with Cuba’s Center for Molecular Immunology. But there are actually two parallel medical initiatives pursuing commercialization of the human cancer … Read more

U.S. and Cuba Agree to Cancer Collaboration

U.S. and Cuba Agree to Cancer Collaboration

Yesterday, Cuba and the U.S. signed a memorandum of understanding for collaboration around cancer. The agreement, signed by Dr. Ro­berto Morales Ojeda, Cuban Minister of Public Health, and Sylvia Burwell, Secretary of the U.S. Health and Human Services, seeks to combine forces to combat cancer through collaboration. Joint meetings, conferences and workshops will promoting exchange … Read more